NIH Oral Interview:
"Walter Koroshetz (2022)"
Koroshetz: "The big surprise was that people who were never in the hospital were also going to those clinics because they weren't getting better weeks or months after COVID. People on popular social media were getting together and coined this term "Long COVID" to describe the symptoms that people are having chronically. That is another big problem with COVID—these persistent symptoms. Congress then appropriated 1.15 billion dollars to NIH to try and understand that Long-COVID syndrome and also to look at the long-term effects of COVID. NHLBI is the lead of the RECOVER..there's 10,000 people already enrolled that we're studying, trying to understand what's wrong and what the biological nature of the problem is."
The RECOVER project is a major project, but it's a really important one. It's really close to NINDS because about ten years ago, Dr. Collins asked us to take over—with NIAID, Dr. Fauci's institute—research on what's called "myalgic encephalomyelitis/chronic fatigue syndrome (MECFS)." That is another condition that is very difficult to understand. No one really understands it.... We think that ME/CFS is very similar to long COVID. We don't know for sure, but the symptoms overlap almost perfectly'
'You really need the people who are suffering to inform what you're doing. Patients have been involved from the beginning in trying to understand what's most important to them and what we should target, and also in the design of the studies and the leadership of the RECOVER group. It's worked out really well.
'I would say that having worked in ME/CFS for a number of years and not really feeling like we're getting anywhere, I thought it was really important to do something that leaves no-stone-unturned in terms of delving into what this problem is. In ME/CFS, what you see is a lot of small studies that report something abnormal, but it's just that small group. It's hard to reproduce. What we didn't want to have in long COVID is a lot of small studies going down a path that's the wrong path, so we decided to do it in a much more comprehensive and large fashion. That took a lot of time to set up—but with record recruitment of 10,000 people within a year.'
'Right now, we'd really like to dig deep into the underpinnings of this problem and also try things to see if we can improve patients a lot.'
'I'm just hoping that we can find better treatments with Long COVID. That's my first thought now.'